CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Jul. 31, 2016	Jul. 31, 2015
Operating Expenses:
Research and development	$ 467,382	$ 1,185,384
General and administrative	1,435,186	2,377,530
Total Operating Expenses	1,902,568	3,562,914
Operating Loss	(1,902,568)	(3,562,914)
Other Income/(Expense):
Impairment of patents	(1,165,864)	(320,160)
Interest income		6
Interest expense	(418,500)	(350,028)
Change in fair value of derivative liabilities	263,823	1,488,237
Gain on extinguishment of debt		551,501
Net Income/(Loss)	(3,223,109)	(2,193,358)
Preferred Stock Dividend		339,583
Net Loss Available to Common Stockholders	$ (3,223,109)	$ (2,532,941)
Basic and Diluted Net Loss Per Common Share	$ (0.004)	$ (0.003)
Weighted Average Number of Shares of Common Stock Outstanding - basic and diluted	880,941,375	793,346,901
Other Comprehensive (Loss) / Income
Net Income/(Loss)	$ (3,223,109)	$ (2,193,358)
Change in foreign currency translation adjustments	(9,865)	36,663
Comprehensive Loss	(3,232,974)	(2,156,695)
Preferred Stock Dividend		339,583
Comprehensive Loss Available to Common Stockholders	$ (3,232,974)	$ (2,496,278)